RATIONALE: Costimulatory molecules, including the CD40-CD154 and CD80/86-CD28 dyads, play a prominent role in regulating inflammation in the adaptive immune response. Studies from our group and others suggest a potentially important role for these costimulatory cascades in innate immunity as well. OBJECTIVES: To determine the role of CD80/86 alone and in combination with CD40 in lethal polymicrobial sepsis in mice and humans. METHODS: The murine cecal ligation and puncture (CLP) model was used to determine the role of CD80/86 alone and in combination with CD40 using wild-type mice, CD80/86(-/-) mice, and novel CD40/80/86(-/-) mice. Expression of cell-bound and soluble costimulatory molecules was assessed in humans via ELISA and flow cytometry. MEASUREMENTS AND MAIN RESULTS: Lethal CLP was associated with up-regulation of CD40 and CD80/86 and their respective ligands CD28 and CD154 on innate effector cells. Blockade or deletion of CD80/86 attenuated mortality and inflammatory cytokine production during CLP. CD40/80/86(-/-) mice exhibited further reductions in mortality, lung injury, and inflammatory cytokine production compared with CD80/86(-/-) mice. Finally, humans with sepsis had increased monocyte expression of CD40 and CD80 compared with healthy control subjects; with higher levels in subjects requiring vasopressor support. Levels of soluble CD28 and CD154 were significantly higher in patients who died compared with those who lived. CONCLUSIONS: These data demonstrate a central role for CD40 and CD80/86 in the innate immune response and suggest that combined inhibition of CD40 and CD80/86 may improve mortality in sepsis. Expression of costimulatory molecules may serve as biomarkers for outcome in septic patients.
RATIONALE: Costimulatory molecules, including the CD40-CD154 and CD80/86-CD28 dyads, play a prominent role in regulating inflammation in the adaptive immune response. Studies from our group and others suggest a potentially important role for these costimulatory cascades in innate immunity as well. OBJECTIVES: To determine the role of CD80/86 alone and in combination with CD40 in lethal polymicrobial sepsis in mice and humans. METHODS: The murine cecal ligation and puncture (CLP) model was used to determine the role of CD80/86 alone and in combination with CD40 using wild-type mice, CD80/86(-/-) mice, and novel CD40/80/86(-/-) mice. Expression of cell-bound and soluble costimulatory molecules was assessed in humans via ELISA and flow cytometry. MEASUREMENTS AND MAIN RESULTS: Lethal CLP was associated with up-regulation of CD40 and CD80/86 and their respective ligands CD28 and CD154 on innate effector cells. Blockade or deletion of CD80/86 attenuated mortality and inflammatory cytokine production during CLP. CD40/80/86(-/-) mice exhibited further reductions in mortality, lung injury, and inflammatory cytokine production compared with CD80/86(-/-) mice. Finally, humans with sepsis had increased monocyte expression of CD40 and CD80 compared with healthy control subjects; with higher levels in subjects requiring vasopressor support. Levels of soluble CD28 and CD154 were significantly higher in patients who died compared with those who lived. CONCLUSIONS: These data demonstrate a central role for CD40 and CD80/86 in the innate immune response and suggest that combined inhibition of CD40 and CD80/86 may improve mortality in sepsis. Expression of costimulatory molecules may serve as biomarkers for outcome in septicpatients.
Authors: Dirk Homann; Angelika Jahreis; Tom Wolfe; Anna Hughes; Bryan Coon; Marianne J B van Stipdonk; Kiley R Prilliman; Stephen P Schoenberger; Matthias G von Herrath Journal: Immunity Date: 2002-03 Impact factor: 31.745
Authors: A O Tzianabos; A Chandraker; W Kalka-Moll; F Stingele; V M Dong; R W Finberg; R Peach; M H Sayegh Journal: Infect Immun Date: 2000-12 Impact factor: 3.441
Authors: Hiroshi Kobayashi; Anna Nolan; Bushra Naveed; Yoshihiko Hoshino; Leopoldo N Segal; Yoko Fujita; William N Rom; Michael D Weiden Journal: J Immunol Date: 2010-11-22 Impact factor: 5.422
Authors: Neil R Aggarwal; Franco R D'Alessio; Kenji Tsushima; D Clark Files; Mahendra Damarla; Venkataramana K Sidhaye; Mostafa M Fraig; Vsevolod Y Polotsky; Landon S King Journal: Am J Physiol Lung Cell Mol Physiol Date: 2009-12-24 Impact factor: 5.464
Authors: Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Jason R Mock; Yoshiki Eto; Brian T Garibaldi; Daniel C Files; Claudia R Avalos; Jackie V Rodriguez; Adam T Waickman; Sekhar P Reddy; David B Pearse; Venkataramana K Sidhaye; Paul M Hassoun; Michael T Crow; Landon S King Journal: J Immunol Date: 2012-07-27 Impact factor: 5.422
Authors: Neil R Aggarwal; Franco R D'Alessio; Yoshiki Eto; Eric Chau; Claudia Avalos; Adam T Waickman; Brian T Garibaldi; Jason R Mock; Daniel C Files; Venkataramana Sidhaye; Vsevolod Y Polotsky; Jonathan Powell; Maureen Horton; Landon S King Journal: Am J Respir Cell Mol Biol Date: 2013-05 Impact factor: 6.914
Authors: Anna Nolan; Hiroshi Kobayashi; Bushra Naveed; Ann Kelly; Yoshihiko Hoshino; Satomi Hoshino; Matthew R Karulf; William N Rom; Michael D Weiden; Jeffrey A Gold Journal: PLoS One Date: 2009-08-12 Impact factor: 3.240